Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
Clinical trial NCT04468984 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04468984
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2025-01-29
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.